Skip to main content
Journal of Creative Research in
English Literature and Culture
ISSN No.: 3108-0812

Patent and Consent Policy

Patent and Consent Policy - JCRELC
Intellectual Property Protection and Research Consent Guidelines

JCRELC recognizes the protection of intellectual property rights while encouraging dissemination of scholarly research. This policy on patent and consent addresses the complex intersection of academic publishing, patent protection, and ethical research conduct.

The Journal of Creative Research in English Literature and Culture (JCRELC) is committed to protecting intellectual property rights while fostering the open exchange of scholarly research. This policy guides authors through considerations about patents, obtains proper consent for research involving human subjects, and describes how intellectual property issues may be handled in the publication process.

Patent Considerations and Disclosure

Required Disclosures
  • Pending patent applications
  • Patents granted related to the research
  • Planned patent filings
  • Institutional patent policies
  • Commercialization agreements
  • Material Transfer Agreements
  • Confidentiality constraints
Timing of Disclosure
  • During manuscript submission
  • Prior to peer review initiation
  • Before manuscript acceptance
  • Upon discovery of new patent issues
  • During revision process, if applicable
  • Before final publication

Note: Authors must disclose patent-related information at the time of manuscript submission. This includes patent application status, numbers, jurisdictions, inventor names, and licensing status.

Publication and Patentability

Possible Impacts
  • Prior art creation that influences novelty
  • Public disclosure triggering deadlines
  • Variations in grace periods among jurisdictions
  • Impact on international patent filings
  • Commercial value implications
  • Licensing opportunity considerations
Recommended Actions
  • Consult with patent attorneys before submitting
  • File patent applications prior to publication
  • Understand jurisdiction-specific grace periods
  • Coordinate with institutional technology transfer offices
  • Consider provisional patent applications
  • Plan international filing strategies

Important: Publication of research in JCRELC (including online open access) may constitute prior art that can affect patentability. Authors are strongly advised to file patent applications before submitting their manuscript to the journal.

International Patent Grace Periods

Jurisdiction Grace Period Conditions
United States 12 months From first public disclosure by inventor
Japan 12 months From first public disclosure
South Korea 12 months From first public disclosure
Canada 12 months From first public disclosure
Australia 12 months From first public disclosure
European Patent Office 6 months Limited circumstances only
China 6 months Limited to some international exhibitions
India 12 months From first public disclosure

Important Legal Notice: Grace periods are complex and subject to change. Authors should consult with patent professionals in relevant jurisdictions before publication.

Patent Strategy Recommendations

File First, Publish Later

Submit patent applications before manuscript submission to secure priority dates.

Provisional Applications

Use provisional patents to establish early filing dates while continuing research.

International Filing

Plan PCT applications for comprehensive international patent protection.

Institutional Support

Collaborate with university technology transfer offices for guidance and support.

Ethical Approval and Compliance

Required Approvals
  • Institutional Review Board (IRB) approval
  • Research Ethics Committee clearance
  • Institutional animal care committee approval
  • Data protection authority approval
  • Indigenous community approval
  • Government research permits
Compliance Documentation
  • Approval certificate numbers
  • Date of ethical approval
  • Name of approving institution
  • Approval validity period
  • Any special conditions
  • Renewal documentation if applicable

Ethical Compliance Statement Requirement: Manuscripts reporting research involving human subjects, animal subjects, or sensitive data should include a statement identifying the institutional review board or ethics committee that approved the study, along with the reference number where appropriate.

Frequently Asked Questions

Strongly recommended. In most jurisdictions (especially Europe, China, Japan), publication prior to filing destroys novelty. Even in jurisdictions with grace periods, filing before submission is the safest approach. Consult your institution's technology transfer office or patent attorney.

Yes. Including patent application numbers is permitted and does not affect patent rights. This helps readers understand the commercial potential of your research and can be included in the manuscript text, footnotes, or conflict of interest statement.

No. JCRELC does not claim any ownership or rights to patents resulting from published research. Authors retain full patent rights. The Copyright Transfer Agreement applies only to the article text and figures, not to underlying inventions or patents.

This is common. Authorship and inventorship have different legal standards. Not all authors need to be inventors, and not all inventors need to be authors. Disclose this situation in the cover letter and conflict of interest statement to avoid confusion.

Yes. In absolute novelty jurisdictions, preprint posting may destroy novelty. Even in grace period jurisdictions, preprints may create prior art. File a patent application before posting any preprint. Consult your patent attorney for jurisdiction-specific advice.

Include a clear statement: "Author [Name] is a named inventor on patent application [number] related to this work and has a financial interest in its commercialization." If no commercialization yet: "Author [Name] is a named inventor on a pending patent application related to this work."

Related Policies

Patent and Consent Support

For further inquiries on questions of patent considerations, consent requirements, ethical approvals, or intellectual property issues, kindly contact our Editorial Office.

Phone:
+91-7665235235

Subject Line Requirement: Please put "Patent and Consent Query" in the subject line of your email and describe your situation in as much detail as possible.

Legal Guidance: Contact us early for guidance on patent and consent matters to avoid publication delays.